Clinical trial of<i>Rhodiola rosea</i>L. extract SHR-5 in the treatment of mild to moderate depression

V. Darbinyan(Yerevan State Medical University), Alexander Panossian(Sandvik (Sweden)), G. Aslanyan(Institute of Fine Organic Chemistry of Scientific - Technological Center of Organic and Pharmaceutical Chemistry), E. Amroyan(Institute of Fine Organic Chemistry of Scientific - Technological Center of Organic and Pharmaceutical Chemistry), Chira Mälmström, E. Gabrielyan(Institute of Fine Organic Chemistry of Scientific - Technological Center of Organic and Pharmaceutical Chemistry)
Nordic Journal of Psychiatry
January 1, 2007
10.1080/08039480701643290
Cited by 216

Related Papers

Rosenroot (Rhodiola rosea): Traditional use, chemical composition, pharmacology and clinical efficacy
|Phytomedicine|2010|594
Pharmacology of Schisandra chinensis Bail.: An overview of Russian research and uses in medicine
|Journal of Ethnopharmacology|2008|521
Herbal medicine for depression, anxiety and insomnia: A review of psychopharmacology and clinical evidence
|European Neuropsychopharmacology|2011|465
Evolution of the adaptogenic concept from traditional use to medical systems: Pharmacology of stress‐ and aging‐related diseases
|Medicinal Research Reviews|2020|328
Rhodiola rosea in stress induced fatigue — A double blind cross-over study of a standardized extract SHR-5 with a repeated low-dose regimen on the mental performance of healthy physicians during night duty
|Phytomedicine|2000|275